257875-30-2

Basic information

• Product Name: 2-[(S)-7-(tert-butyldiphenylsilyloxymethyl)-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]acetamide
• Synonyms: 2-[(S)-7-(tert-butyldiphenylsilyloxymethyl)-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]acetamide
• CAS NO: 257875-30-2
• Molecular Weight: 496.725
• Mol File: 257875-30-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-[(S)-7-(tert-butyldiphenylsilyloxymethyl)-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[(S)-7-(tert-butyldiphenylsilyloxymethyl)-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]acetamide(257875-30-2)
• EPA Substance Registry System: 2-[(S)-7-(tert-butyldiphenylsilyloxymethyl)-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]acetamide(257875-30-2)

Safety Data

• Hazardous Substances Data: 257875-30-2(Hazardous Substances Data)

Upstream product

• 134665-15-9 (S)-2-(acetoxymethyl)-4,4-diethoxybutyl methanesulfonate 
• 144461-19-8 (R)-2-(2,2-diethoxyethyl)-1,3-propanediol monoacetate 
• 257876-70-3 (S)-2-(tert-butyldiphenylsilyloxymethyl)-4,4-diethoxybutyl methanesulfonate 
• 908338-26-1 Methanesulfonic acid (S)-4,4-diethoxy-2-hydroxymethyl-butyl ester 
• 257875-28-8 2-{1-[(S)-2-(tert-butyldiphenylsilyloxymethyl)-4,4-diethoxybutyl]-1H-indol-3-yl}acetamide 

Relevant articles and documents

Synthesis, SAR studies, and pharmacological evaluation of 3-anilino-4-(3-indolyl) maleimides with conformationally restricted structure as orally bioavailable PKCβ-selective inhibitors

Conformationally restricted 3-anilino-4-(3-indolyl)maleimide derivatives were designed and synthesized aiming at discovery of novel protein kinase Cβ (PKCβ)-selective inhibitors possessing oral bioavailability. Among them, compounds having a fused five-me